Skip to main content
OpenTrials
Completed

NCT Number: NCT05767138

STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 12-17 years of age, with guardian consent
  • 18 years or older
  • Male or Female
  • Living in Mèkin-Sikoro and Djikoroni

Exclusion criteria

  • 12-17 years of age, without guardian consent
  • <12 years of age
  • Living outside Mèkin-Sikoro and Djikoroni

Treatment and study plan

HPV Vaccine Acceptance Survey

Behavioral

Primary outcomes

  1. Participants' acceptance of the vaccine

    Time frame: immediately after the intervention

    Number of participants willing to be vaccinated against HPV and their vaccination preferences after educational sessions

Secondary outcomes

  1. Knowledge of STIs, HPV, and Cervical Cancer

    Time frame: immediately after the intervention

    Knowledge Question asked before and after educational session

Sponsors and collaborators

Lead sponsor

Global Alliance to Immunize Against AIDS Vaccine Foundation

Other

Collaborators

  • Merck Sharp & Dohme LLC

Registry information

Official study title

Knowledge, Attitudes, Practices and Willingness to Vaccinate in Preparation for the Introduction of HPV Vaccines in Bamako, Mali

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Mar 14, 2023
Registry last updated
Mar 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.